Accepting new patients (614) 430-8022 7965 N High St, Suite 205
Optimed Immunology
Patient Portal Schedule Consultation

What is Firazyr (Icatibant)?

Icatibant is a bradykinin B2 receptor antagonist for acute treatment of HAE attacks. Available as Firazyr (Takeda), Sajazir (Cycle Pharmaceuticals), and as a generic. The subcutaneous route makes it convenient for patient self-administration at home or while traveling, allowing early treatment of attacks. Selection among brand and generic options is typically driven by insurance coverage and copay assistance.

What it treats

Firazyr (Icatibant) is FDA-approved for the following indications:

  • Treatment of acute attacks of HAE in adults

How it is administered

Icatibant is administered as a subcutaneous self-injection at attack onset. Patients are prescribed multiple doses for home stocking and trained on technique. Brand selection (Firazyr, Sajazir, or generic) is coordinated with the patient's insurance and pharmacy.

Patient assistance & support

The manufacturer offers a patient support program — Takeda OnePath — that can help with insurance navigation, copay assistance for eligible patients, nursing support, and ongoing education. More information is available at https://www.takedapatientsupport.com.

Coordination at Optimed Immunology

Treatment with Firazyr (Icatibant) is initiated and monitored by Dr. McNeil. Prior authorizations are handled in-house — patients are not asked to navigate insurance approvals on their own. This is a subcutaneous self-administered medication. After prior authorization, the prescription is sent to a specialty pharmacy that ships the medication directly to the patient. A manufacturer-sponsored nurse or office-based training visit is typically arranged for the first dose so patients are confident with self-administration before continuing at home.

Important safety note: This page is not a substitute for the FDA prescribing information. Risks, contraindications, drug interactions, and required monitoring vary by patient. The official manufacturer website (https://www.firazyr.com) provides the most current full prescribing and safety information. Treatment decisions and monitoring are individualized — please discuss with Dr. McNeil whether Firazyr (Icatibant) is appropriate for your situation.

Medically reviewed

Donald L. McNeil, MD · Board Certified in Allergy & Immunology and Internal Medicine

Last reviewed: November 2025 · Sources: FDA prescribing information · manufacturer label · AAAAI · ACAAI · relevant clinical guidelines

This page is provided for educational purposes only and is not medical advice. If you have an emergency, call 911.

Have questions about Firazyr (Icatibant)?

Treatment selection is a shared decision. Schedule a consultation with Dr. McNeil to discuss whether Firazyr (Icatibant) is appropriate for you.